drug
as of 2026-07-01Antipsychotic Agents
MeSH D014150
at a glance
small molecule
Pre-approval / investigational in the US
Developed by The University of Hong Kong
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
1
Berberine as Adjuvant Treatment for Schizophrenia Patients
NCT02983188Phase 2, Phase 3Completed
KOLs & investigators
1
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
trial
indication
indication
indication
indication
KOL
Zhang-Jin ZHANG, MMed, PhD
personKOL score —